Skip to main content
. 2019 Jul 2;2019:1342190. doi: 10.1155/2019/1342190

Figure 1.

Figure 1

miR-30-5p was downregulated in patients with atherosclerosis and its functional enrichment analysis. (a) The expression levels of miR-30-5p in patients with atherosclerosis (patients) and normal healthy people (control) were determined by qRT-PCR. (b) GO analysis of miR-30-5p involved in different diseases. (c) KEGG analysis of miR-30-5p involved in different signal pathways. (d) Molecular function analysis of miR-30-5p by GO.